Compulsive eating and weight gain related to dopamine agonist use
- 31 October 2005
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 21 (4), 524-529
- https://doi.org/10.1002/mds.20757
Abstract
Dopamine agonists have been implicated in causing compulsive behaviors in patients with Parkinson's disease (PD). These have included gambling, hypersexuality, hobbyism, and other repetitive, purposeless behaviors (“punding”). In this report, we describe 7 patients in whom compulsive eating developed in the context of pramipexole use. All of the affected patients had significant, undesired weight gain; 4 had other comorbid compulsive behaviors. In the 5 patients who lowered the dose of pramipexole or discontinued dopamine agonist treatment, the behavior remitted and no further weight gain occurred. Physicians should be aware that compulsive eating resulting in significant weight gain may occur in PD as a side‐effect of dopamine agonist medications such as pramipexole. Given the known risks of the associated weight gain and obesity, further investigation is warranted. © 2005 Movement Disorder SocietyKeywords
This publication has 31 references indexed in Scilit:
- Pathological Gambling Caused by Drugs Used to Treat Parkinson DiseaseArchives of Neurology, 2005
- Pathological gambling in two patients on dopamine replacement therapy for Parkinson?s diseaseNeurological Sciences, 2004
- Repetition, repetition, and repetition: Compulsive and punding behaviors in parkinson's diseaseMovement Disorders, 2004
- Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndromeMovement Disorders, 2004
- Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?The Lancet Neurology, 2003
- Pathological gambling associated with dopamine agonist therapy in Parkinson’s diseaseNeurology, 2003
- Pathologic Gambling in Patients with Parkinson's DiseaseClinical Neuropharmacology, 2001
- Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment?Movement Disorders, 2000
- Punding onL-dopaMovement Disorders, 1999
- Punding on levodopaBiological Psychiatry, 1994